Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Waning immunity of the BNT162b2 vaccine: A nationwide study from Israel
Yair Goldberg, Micha Mandel, Yinon M. Bar-On, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 109

Showing 1-25 of 109 citing articles:

Covid-19 Vaccine Effectiveness against the Omicron (B.1.1.529) Variant
Nick Andrews, Julia Stowe, Freja Kirsebom, et al.
New England Journal of Medicine (2022) Vol. 386, Iss. 16, pp. 1532-1546
Open Access | Times Cited: 2091
Comparing COVID-19 vaccines for their characteristics, efficacy and effectiveness against SARS-CoV-2 and variants of concern: a narrative review
Thibault Fiolet, Yousra Kherabi, Conor-James MacDonald, et al.
Clinical Microbiology and Infection (2021) Vol. 28, Iss. 2, pp. 202-221
Open Access | Times Cited: 820
Effect of Delta variant on viral burden and vaccine effectiveness against new SARS-CoV-2 infections in the UK
Koen B. Pouwels, Emma Pritchard, Philippa C. Matthews, et al.
Nature Medicine (2021) Vol. 27, Iss. 12, pp. 2127-2135
Open Access | Times Cited: 533
SARS-CoV-2 Omicron has extensive but incomplete escape of Pfizer BNT162b2 elicited neutralization and requires ACE2 for infection
Sandile Cele, Laurelle Jackson, David S. Khoury, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 342
SARS-CoV-2 breakthrough infections in vaccinated individuals: measurement, causes and impact
Marc Lipsitch, Florian Krammer, Gili Regev‐Yochay, et al.
Nature reviews. Immunology (2021) Vol. 22, Iss. 1, pp. 57-65
Open Access | Times Cited: 305
SARS-CoV-2 vaccine protection and deaths among US veterans during 2021
Barbara A. Cohn, Piera M. Cirillo, Caitlin C. Murphy, et al.
Science (2021) Vol. 375, Iss. 6578, pp. 331-336
Open Access | Times Cited: 241
Viral loads of Delta-variant SARS-CoV-2 breakthrough infections after vaccination and booster with BNT162b2
Matan Levine-Tiefenbrun, Idan Yelin, Hillel Alapi, et al.
Nature Medicine (2021) Vol. 27, Iss. 12, pp. 2108-2110
Open Access | Times Cited: 234
Effectiveness of COVID-19 vaccines against the Omicron (B.1.1.529) variant of concern
Nick Andrews, Julia Stowe, Freja Kirsebom, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 188
Effectiveness of Covid-19 Vaccines over a 9-Month Period in North Carolina
Dan-Yu Lin, Yu Gu, Bradford Wheeler, et al.
New England Journal of Medicine (2022) Vol. 386, Iss. 10, pp. 933-941
Open Access | Times Cited: 181
mRNA Vaccines in the COVID-19 Pandemic and Beyond
Michael J. Hogan, Norbert Pardi
Annual Review of Medicine (2021) Vol. 73, Iss. 1, pp. 17-39
Open Access | Times Cited: 177
Vaccine effectiveness and duration of protection of Comirnaty, Vaxzevria and Spikevax against mild and severe COVID-19 in the UK
Nick Andrews, Elise Tessier, Julia Stowe, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 167
Mitigating Covid-19 in the face of emerging virus variants, breakthrough infections and vaccine hesitancy
Azizul Haque, Anudeep B. Pant
Journal of Autoimmunity (2022) Vol. 127, pp. 102792-102792
Open Access | Times Cited: 164
Protection against Covid-19 by BNT162b2 Booster across Age Groups
Yinon M. Bar-On, Yair Goldberg, Micha Mandel, et al.
New England Journal of Medicine (2021) Vol. 385, Iss. 26, pp. 2421-2430
Open Access | Times Cited: 133
COVID vaccine immunity is waning — how much does that matter?
Elie Dolgin
Nature (2021) Vol. 597, Iss. 7878, pp. 606-607
Open Access | Times Cited: 121
Delta Variants of SARS-CoV-2 Cause Significantly Increased Vaccine Breakthrough COVID-19 Cases in Houston, Texas
Paul A. Christensen, Randall J. Olsen, Sheng Long, et al.
American Journal Of Pathology (2021) Vol. 192, Iss. 2, pp. 320-331
Open Access | Times Cited: 110
Efficacy of a third BNT162b2 mRNA COVID-19 vaccine dose in patients with CLL who failed standard 2-dose vaccination
Yair Herishanu, Galia Rahav, Shai Levi, et al.
Blood (2021) Vol. 139, Iss. 5, pp. 678-685
Open Access | Times Cited: 110
COVID-19 Vaccine Booster Hesitancy (VBH) of Healthcare Workers in Czechia: National Cross-Sectional Study
Miloslav Klugar, Abanoub Riad, Lekshmi Mohanan, et al.
Vaccines (2021) Vol. 9, Iss. 12, pp. 1437-1437
Open Access | Times Cited: 106
Nosocomial outbreak caused by the SARS-CoV-2 Delta variant in a highly vaccinated population, Israel, July 2021
Pnina Shitrit, Neta S. Zuckerman, Orna Mor, et al.
Eurosurveillance (2021) Vol. 26, Iss. 39
Open Access | Times Cited: 74
Long-term immunogenicity of BNT162b2 vaccination in older people and younger health-care workers
Pinkus Tober‐Lau, Tatjana Schwarz, Kanika Vanshylla, et al.
The Lancet Respiratory Medicine (2021) Vol. 9, Iss. 11, pp. e104-e105
Open Access | Times Cited: 74
Equivalency of Protection From Natural Immunity in COVID-19 Recovered Versus Fully Vaccinated Persons: A Systematic Review and Pooled Analysis
Mahesh B. Shenai, Ralph Rahme, Hooman Noorchashm
Cureus (2021)
Open Access | Times Cited: 72
Effectiveness of BNT162b2 (Comirnaty, Pfizer-BioNTech) COVID-19 booster vaccine against covid-19 related symptoms in England: test negative case-control study
Nick Andrews, Julia Stowe, Freja Kirsebom, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 61
Two-dose SARS-CoV-2 vaccine effectiveness with mixed schedules and extended dosing intervals: test-negative design studies from British Columbia and Quebec, Canada
Danuta M. Skowronski, Solmaz Setayeshgar, Yossi Febriani, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 60
Additional heterologous versus homologous booster vaccination in immunosuppressed patients without SARS-CoV-2 antibody seroconversion after primary mRNA vaccination: a randomised controlled trial
Michael Bonelli, Daniel Mrak, Selma Tobudic, et al.
Annals of the Rheumatic Diseases (2022) Vol. 81, Iss. 5, pp. 687-694
Open Access | Times Cited: 56
Delta variants of SARS-CoV-2 cause significantly increased vaccine breakthrough COVID-19 cases in Houston, Texas
Paul Christensen, Randall J. Olsen, S. Wesley Long, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 43
Covid-19 vaccination: evidence of waning immunity is overstated
Jake Scott, Aaron Richterman, Müge Çevik
BMJ (2021), pp. n2320-n2320
Open Access | Times Cited: 42
Page 1 - Next Page

Scroll to top